Fortis Healthcare signs O&M agreement with Ekana Group for 550-bed hospital in Lucknow
The facility will be positioned as a Centre of Excellence for tertiary care services
The facility will be positioned as a Centre of Excellence for tertiary care services
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Phase 1 dosing is expected to finish by the end of 2025
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
Subscribe To Our Newsletter & Stay Updated